Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Orforglipron

ATTAIN-2

Eli Lilly · Phase 3 · Completed · Enrollment 1613

NCT05872620

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Placebo53 participants24 participants94 participantsn/r4
6 mg Orforglipron QD66 participants42 participants70 participantsn/r0
12 mg Orforglipron QD103 participants67 participants82 participantsn/r4
36 mg Orforglipron QDn/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.